- Home
- BLX vs BBNX Comparison
BLX vs BBNX Comparison
Compare BLX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLX | BBNX |
|---|---|---|
| Founded | 1977 | 2015 |
| Country | Panama | United States |
| Employees | 322 | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | BLX | BBNX |
|---|---|---|
| Price | $43.11 | $31.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $28.92 |
| AVG Volume (30 Days) | 139.8K | ★ 928.2K |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | ★ 5.67% | N/A |
| EPS Growth | ★ 9.67 | N/A |
| EPS | ★ 6.00 | N/A |
| Revenue | ★ $308,426,000.00 | $88,570,000.00 |
| Revenue This Year | $18.35 | $52.13 |
| Revenue Next Year | $6.56 | $36.16 |
| P/E Ratio | $7.34 | ★ N/A |
| Revenue Growth | 10.24 | ★ 67.01 |
| 52 Week Low | $31.14 | $8.89 |
| 52 Week High | $48.38 | $32.71 |
Technical Indicators
Market Signals| Indicator | BLX | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 36.68 | 55.06 |
| Support Level | $43.60 | $28.36 |
| Resistance Level | $44.73 | $32.21 |
| Average True Range (ATR) | 0.78 | 1.66 |
| MACD | -0.09 | -0.18 |
| Stochastic Oscillator | 2.56 | 66.89 |
Price Performance
Historical ComparisonAbout BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.